October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart ...
October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...
October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...
October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...
October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the ...
October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...
October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections ...
October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy ...
October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...
October 16, 2023
